In what Lawrence Livermore National Lab said is “a substantial milestone for supercomputing-aided drug design,” LLNL and BridgeBio Oncology Therapeutics today announced clinical trials have begun for ….
In what Lawrence Livermore National Lab said is “a substantial milestone for supercomputing-aided drug design,” LLNL and BridgeBio Oncology Therapeutics today announced clinical trials have begun for ….
[SPONSORED GUEST WHITE PAPER] This white paper spotlights Eviden’s Center for Excellence in Performance Programming (CEPP), which empowers organizations to ….
Getting the benefits of big data analytics can be challenging, but it is a necessary endeavor for any organization to succeed going forward. Understanding the challenges to maximizing big data analytics and DL, and how to overcome them, is crucial. Determining your expectations up front, and carefully orchestrating your infrastructure build, will allow you to construct an architecture […]